Arie Mayer insider trades

Open-market stock purchases and sales by Arie Mayer, Director at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since Jan 8, 2020.

Recent trades

DateStockTradeValue
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—

Companies traded

  • ORMP Oramed Pharmaceuticals Inc: 2 buys, 1 sale, last Dec 31, 2025

Get free alerts when Arie Mayer files a new trade →